ResMed Inc. Unveils Stewardship Presentation Highlighting Fiscal 2025 Achievements and 2030 Strategy

Reuters
Sep 13
ResMed Inc. Unveils Stewardship Presentation Highlighting Fiscal 2025 Achievements and 2030 <a href="https://laohu8.com/S/MSTR">Strategy</a>

ResMed Inc. recently shared highlights from its fiscal 2025 performance, focusing on its strategy for 2030. The company reported a revenue of $5.1 billion with an operating margin of 33% GAAP and 34% Non-GAAP. ResMed serves over 140 countries and employs more than 10,000 people. Their revenue by business is divided among Devices, Masks & Other, and Residential Care Software $(RCS)$, while regional revenue is primarily from the U.S., Canada, and Latin America. The company's focus areas include enhancing patient experience through innovative solutions for Sleep Apnea, improving outcomes for COPD patients, and providing residential care software solutions. ResMed aims to empower 500 million lives by 2030 and has already impacted over 154 million lives with its digital health products and cloud-based software solutions in the past year. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on September 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10